Calgary

Dr Tolu Sajobi is an Associate Professor of Biostatistics in the Departments of Community Health Sciences and Clinical Neurosciences at the University of Calgary. His research program focuses on measurement and analysis of patient-reported outcomes, design and analysis of clinical trials, and development and implementation of clinical decision aids.

Dr Tolu Sajobi is an Associate Professor of Biostatistics in the Departments of Community Health Sciences and Clinical Neurosciences at the University of Calgary. His research program focuses on measurement and analysis of patient-reported outcomes, design and analysis of clinical trials, and development and implementation of clinical decision aids.

Stroke neurologist and clinical trialist with interests in neuro-epidemiology and advancing therapeutics in stroke and neurology.  I also have a role in the province as medical lead for cardiovascular and stroke.

Stroke neurologist and clinical trialist with interests in neuro-epidemiology and advancing therapeutics in stroke and neurology.  I also have a role in the province as medical lead for cardiovascular and stroke.

Dr Tolu Sajobi is an Associate Professor of Biostatistics in the Departments of Community Health Sciences and Clinical Neurosciences at the University of Calgary. His research program focuses on measurement and analysis of patient-reported outcomes, design and analysis of clinical trials, and development and implementation of clinical decision aids.

Dr Tolu Sajobi is an Associate Professor of Biostatistics in the Departments of Community Health Sciences and Clinical Neurosciences at the University of Calgary. His research program focuses on measurement and analysis of patient-reported outcomes, design and analysis of clinical trials, and development and implementation of clinical decision aids.

Dr. Matthew James is a specialist in Nephrology and an Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary. Dr. James received his medical training at the University of British Columbia, and completed nephrology training and a PhD in Epidemiology at the University of Calgary. He is a co-lead of the Alberta Kidney Disease Network (AKDN), Interdisciplinary Chronic Disease Collaboration (ICDC), and the Can-SOLVE CKD Strategy for Patient Oriented Research (SPOR) Network, and director of Research for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH).  Dr. James’ research is focused on risk prediction, computerized decision support tools, and pragmatic trials designed to improve the quality of care and health outcomes of those with kidney and cardiovascular diseases.

Dr. Matthew James is a specialist in Nephrology and an Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Calgary. Dr. James received his medical training at the University of British Columbia, and completed nephrology training and a PhD in Epidemiology at the University of Calgary. He is a co-lead of the Alberta Kidney Disease Network (AKDN), Interdisciplinary Chronic Disease Collaboration (ICDC), and the Can-SOLVE CKD Strategy for Patient Oriented Research (SPOR) Network, and director of Research for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH).  Dr. James’ research is focused on risk prediction, computerized decision support tools, and pragmatic trials designed to improve the quality of care and health outcomes of those with kidney and cardiovascular diseases.